Previous 10 | Next 10 |
2023-06-16 15:00:31 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...
2023-06-12 09:30:39 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Major large cap pharmaceutical firms often dominate the headlines. However, small cap drug companies also contribute significantly to scientific advancements. Drug stocks with ongoing clinical ...
2023-06-09 21:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-06-01 06:45:00 ET Shares of Sarepta Therapeutics (NASDAQ: SRPT) nosedived last week as the Food and Drug Administration (FDA) did not approve the company's gene therapy treatment, SRP-9001. Panic has been setting in, as the stock has been in sell-off mode. Should investors ...
2023-05-31 07:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-05-26 15:00:30 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...
2023-05-25 12:55:40 ET Scholar Rock ( NASDAQ: SRRK ) shares continued to tumble for the second straight session on Thursday in a move attributed to the decision by the FDA to delay its decision on SRP-9001, a gene therapy developed by Sarepta Therapeutics ( SRPT ) for Duchenne m...
2023-05-24 13:53:00 ET Shares of Sarepta Therapeutics (NASDAQ: SRPT) , which focuses on genetic treatments for rare diseases, were down 11.5% Wednesday afternoon after the Food and Drug Administration (FDA) pushed back its Prescription Drug User Fee Act ( PDUFA ) date on a Duche...
2023-05-24 12:18:10 ET Major market averages fell during Wednesday's noon session as debt ceiling negotiations dragged on. Looking at specific stocks, Palo Alto Networks ( NASDAQ: PANW ), retailers Abercrombie & Fitch ( NYSE: ANF ) and Urban Outfitters ...
2023-05-24 08:22:51 ET Sarepta Therapeutics ( NASDAQ: SRPT ) announced Wednesday that the FDA would require additional time to review its marketing application for SRP-9001, a gene therapy targeted at certain patients with Duchenne muscular dystrophy (DMD). The announcement co...
News, Short Squeeze, Breakout and More Instantly...
Sarepta Therapeutics Inc. Company Name:
SRPT Stock Symbol:
NASDAQ Market:
Sarepta Therapeutics Inc. Website:
Rick Barry appointed Executive Chairman of the Board Remi Barbier resigns as President and CEO and from the Board of Directors Cassava initiates search for a new CEO AUSTIN, Texas, July 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today announced that the Boa...
2024-07-08 12:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...